Biohaven annual r&d spending
2020
2021
2022
2023
2024
2025
Biohaven R&D Spending Growth & History (BHVN)
Biohaven's r&d spending was $635.1M for fiscal 2025.
View full Biohaven company overviewBiohaven annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $635.1M | −$160.8M | −20.21% |
| 2024 | 2024-12-31 | $795.9M | $422.6M | +113.21% |
| 2023 | 2023-12-31 | $373.3M | −$63.8M | −14.60% |
| 2022 | 2022-12-31 | $437.1M | $255.6M | +140.83% |
| 2021 | 2021-12-31 | $181.5M | $83.0M | +84.32% |
| 2020 | 2020-12-31 | $98.5M | — | — |
Biohaven quarterly r&d spending
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $100.8M | −$83.6M | −45.32% |
| Q1 2026 | 2026-03-31 | $103.8M | −$83.8M | −44.65% |
| Q4 2025 | 2025-12-31 | $121.9M | −$45.5M | −27.19% |
| Q3 2025 | 2025-09-30 | $141.2M | −$16.4M | −10.43% |
| Q2 2025 | 2025-06-30 | $184.4M | −$130.5M | −41.44% |
| Q1 2025 | 2025-03-31 | $187.6M | $31.6M | +20.27% |
| Q4 2024 | 2024-12-31 | $167.5M | $32.7M | +24.23% |
| Q3 2024 | 2024-09-30 | $157.6M | $62.1M | +65.00% |
| Q2 2024 | 2024-06-30 | $314.8M | $235.3M | +296.05% |
| Q1 2024 | 2024-03-31 | $156.0M | $92.5M | +145.78% |
| Q4 2023 | 2023-12-31 | $134.8M | — | — |
| Q3 2023 | 2023-09-30 | $95.5M | $42.7M | +80.75% |
| Q2 2023 | 2023-06-30 | $79.5M | −$97.6M | −55.11% |
| Q1 2023 | 2023-03-31 | $63.5M | −$6.6M | −9.47% |
| Q3 2022 · Sep 30 | 2022-09-30 | $52.8M | $5.9M | +12.50% |
| Q2 2022 | 2022-06-30 | $177.1M | — | — |
| Q1 2022 | 2022-03-31 | $70.1M | — | — |
| Q3 2021 | 2021-09-30 | $47.0M | — | — |
Biohaven r&d spending trends
Over the last five fiscal years, Biohaven's r&d spending increased from $98.5M to $635.1M, a change of $536.6M. The latest reported quarter, Q2 2026, shows $100.8M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗